Expression of Concern: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.
Main Author: | PLOS ONE Editors |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0233098 |
Similar Items
-
DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine.
by: Fang Liu, et al.
Published: (2014-01-01) -
Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine
Published: (2014-01-01) -
Expression of Concern: Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.
by: PLOS ONE Editors
Published: (2023-01-01) -
Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
by: Amber Blaauboer, et al.
Published: (2020-09-01) -
Retraction: Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer.
by: PLOS ONE Editors
Published: (2024-01-01)